Terrance Lam

Terrance Lam

Auto-generated profile, based on publicly available information

Terrance Lam

Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Australia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2025 in Science Signaling
Verified
Journal Article
Closed access
TLTerrance Lam
Terrance Lam
BCBailey Cardwell
Bailey Cardwell
BLBonan Liu
Bonan Liu
CPCheng Peng
Cheng Peng
MSMia Spark
Mia Spark
MHMichelle L. Halls
Michelle L. Halls
Noradrenaline released from sympathetic neurons accelerates cancer metastasis by activating β 2 -adrenergic receptors (β 2 -adrenoceptors) on tumor cells to promote invasion. We previously showed that the β 2 -adrenoceptor promotes invasive behavior in a metastatic triple-negative breast cancer (TNBC) cell line by activating a cAMP- and calcium-mediated feedforward loop. Here, we found this mechanism in most TNBC lines that have an active β 2 -adrenoceptor. Integrated analysis of transcriptomic datasets revealed HOXC12 , which encodes a developmental homeobox transcription factor, as the most discriminating gene separating cell lines with the feedforward loop and those without it. The high expression of HOXC12 did not correlate with transcriptional changes in integral proteins associated with cAMP or calcium signaling, and immunostaining showed cytosolic localization of Hox-C12, suggesting that it played a nontranscriptional role. Knocking out HOXC12 prevented β 2 -adrenoceptor–mediated calcium signaling and invasion in cultured TNBC cells. In basal breast cancers, HOXC12 expression in tumors negatively correlated with overall and disease-free survival in patients. These findings identify a key mediator, Hox-C12, in the coordination of invasion driven by cAMP and calcium signaling in β 2 -adrenoceptor–responsive TNBC cells.

6 July 2026 in Journal of Experimental Medicine
Verified
Journal Article
Closed access
ACAeson Chang
Aeson Chang
SZShenghong Zhu
Shenghong Zhu
TLTerrance Lam
Terrance Lam
ESErica Sloan
Erica Sloan
The nervous system has emerged as a critical regulator of cancer progression. Recent studies demonstrate that peripheral neurons shape tumor growth, dissemination, and therapeutic response by regulating multiple components of the tumor microenvironment. In parallel, tumors within the body remodel their neural niche by recruiting innervation and modulating neuronal phenotype and activity. This bidirectional cross talk positions neural circuits as integral components of the tumor ecosystem, linking environmental cues, including metabolic stress, inflammation, and the impact of treatment, to coordinated multicellular responses that promote progression and treatment resistance. Here, we review the field of cancer neuroscience with a focus on solid tumors originating outside the central nervous system. We synthesize mechanistic insights into how the peripheral nervous system shapes the tumor microenvironment to influence tumor behavior and highlight emerging therapeutic opportunities to target neural pathways. Together, these findings identify the nervous system as an upstream regulator of cancer biology and a tractable target for intervention.